GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMattioli Woods Regulatory News (MTW)

Share Price Information for Mattioli Woods (MTW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 790.00
Bid: 790.00
Ask: 794.00
Change: 0.00 (0.00%)
Spread: 4.00 (0.506%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 790.00
MTW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Maven Acquisition

1 Jul 2021 07:00

RNS Number : 7470D
Mattioli Woods PLC
01 July 2021
 

1 July 2021

Mattioli Woods plc

("Mattioli Woods", "the Company" or "the Group")

Completion of Maven Acquisition

 

 

Mattioli Woods plc (AIM: MTW.L), the specialist wealth and asset management business, is pleased to announce that its acquisition of Maven Capital Partners UK LLP ("Maven"), previously announced on 26 May 2021, has now completed.

 

Pursuant to the terms of the Maven Acquisition, the Company has allotted 4,545,455 new Ordinary Shares in Mattioli Woods (the "Maven Consideration Shares") to the sellers of Maven. Application has been made for the admission of the Maven Consideration Shares to trading on AIM ("Admission"). Admission of the Maven Consideration Shares, which, when issued, will rank pari passu in all respects with the existing Ordinary Shares, is expected to become effective at 8.00 a.m. on 6 July 2021.

 

The sellers of Maven have entered into lock-in agreements, pursuant to which the Maven Consideration Shares will be subject to a 12-month lock-in period following completion of the Maven Acquisition. Following the initial 12-month lock-in period, the sellers of Maven will be released from the lock-in in respect of, and become free to dispose of, 25 per cent of the Maven Consideration Shares in each of the three years following the first anniversary of completion of the Maven Acquisiton.

 

Total Voting Rights

 

Following Admission, the total number of Ordinary Shares in the Company with voting rights is expected to be 49,775,627. Mattioli Woods does not hold any Ordinary Shares in Treasury.

 

The above figure of 49,775,627 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Ian Mattioli MBE, Chief Executive Officer of Mattioli Woods, said:

 

"We are delighted to complete the acquisition of Maven which marks a significant milestone in Mattioli Woods' journey. The acquisition of Maven enhances our investment proposition and product range and adds opportunities to widen distribution of the enlarged Group's products and services.

 

The team at Maven share our passion for delivering exceptional client outcomes and going the extra mile, and we look forward to welcoming them into the Mattioli Woods group."

 

 

Terms and definitions used in this announcement shall have the same meaning as ascribed to them in the Company's announcements dated 26 May 2021 regarding the Proposed Acquisitions and Proposed Fundraise unless otherwise stated.

 

- Ends -

 

For further information please contact:

Mattioli Woods plc

Ian Mattioli MBE, Chief Executive Officer

Ravi Tara, Chief Financial Officer

Michael Wright, Group Managing Director

Tel: +44 (0) 116 240 8700

www.mattioliwoods.com

 

Canaccord Genuity Limited (Nominated Advisor, Joint Bookrunner and Joint Broker)

Emma Gabriel

Sam Lucas

Tel: +44 (0) 20 7523 8000

Tom Diehl

www.canaccordgenuity.com

N+1 Singer (Joint Bookrunner and Joint Broker)

Justin McKeegan

Tom Salvesen

Tel: +44 (0) 20 7496 3000

Iqra Amin

www.n1singer.com

 

Media enquiries:

Camarco

Ed Gascoigne-Pees

Tel: +44 (0) 20 3757 4984

Julia Tilley

www.camarco.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQEAPKEDANFEFA
Date   Source Headline
10th Oct 20225:00 pmRNSDirector/PDMR Shareholding
3rd Oct 20221:45 pmRNSTotal Voting Rights
28th Sep 20223:00 pmRNSPosting of Annual Report and AGM Notice
28th Sep 20221:00 pmRNSPosting of Annual Report and Notice of AGM
23rd Sep 20226:00 pmRNSDirector/PDMR Shareholding
22nd Sep 20229:00 amRNSExercise of Options
16th Sep 20228:30 amRNSAdditional Block Listing
13th Sep 20227:00 amRNSFinal results
1st Sep 20225:30 pmRNSTotal Voting Rights
1st Aug 20224:00 pmRNSTotal Voting Rights
7th Jul 20225:00 pmRNSBlock listing Interim Review
7th Jul 20227:00 amRNSTrading Update and Notice of Final Results
1st Jul 202211:40 amRNSTotal Voting Rights
1st Jun 20223:30 pmRNSTotal Voting Rights
12th May 20227:00 amRNSAcquisition of Ferguson Financial Management Ltd
10th May 20225:30 pmRNSDirector/PDMR Shareholding
10th May 20222:48 pmRNSHolding(s) in Company
6th May 20227:00 amRNSDirector/PDMR Shareholding
3rd May 202211:00 amRNSTotal Voting Rights
28th Apr 20227:00 amRNSChange of Auditor
26th Apr 20227:00 amRNSDirector/PDMR Shareholding
11th Apr 20227:00 amRNSAppointment of Non-Executive Chairman correction
5th Apr 20224:30 pmRNSDirector/PDMR Shareholding
1st Apr 20221:30 pmRNSDirector/PDMR Shareholding
1st Apr 202211:00 amRNSTotal Voting Rights
31st Mar 20227:00 amRNSDirector/PDMR Shareholding
17th Mar 20225:20 pmRNSHolding(s) in Company
15th Mar 20227:00 amRNSAppointment of Non-Executive Chairman
4th Mar 20224:00 pmRNSDirector/PDMR Shareholding
1st Mar 202211:00 amRNSTotal Voting Rights
15th Feb 20224:40 pmRNSHolding(s) in Company
11th Feb 20225:30 pmRNSDirector/PDMR Shareholding
10th Feb 20226:25 pmRNSHolding(s) in Company
9th Feb 20225:00 pmRNSDirector/PDMR Shareholding
8th Feb 20227:00 amRNSInterim Results
1st Feb 20223:02 pmRNSTotal Voting Rights
21st Jan 20227:00 amRNSUpdate to Appointment of Non-Executive Chairman
7th Jan 20225:41 pmRNSDirector/PDMR Shareholding
7th Jan 20223:59 pmRNSBlock listing Interim Review
6th Jan 20227:00 amRNSTrading Update and Notice of Interim Results
5th Jan 20228:40 amRNSTotal Voting Rights
30th Dec 20215:30 pmRNSDirector/PDMR Shareholding
30th Dec 20214:45 pmRNSAdditional Block Listing
24th Dec 20217:00 amRNSDirector/PDMR Shareholding
17th Dec 20217:00 amRNSTrading Update
13th Dec 20213:56 pmRNSHolding(s) in Company
10th Dec 20213:42 pmRNSHolding(s) in Company
7th Dec 20215:35 pmRNSHolding(s) in Company
1st Dec 202111:00 amRNSTotal Voting Rights
18th Nov 20213:15 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.